EMAIL DETAILS
SUBJECT:
Re: FW: Dates/Times Follow up Meeting Conshohocken- Please Respond ASAP can we confirm May 19th?
PRI: NORMAL
FROM:
R
rwalker@rosemontseneca.com
DATE:
2014-05-13 13:48:29
MSG_ID:
<CANpLt5zGKPdKytfU1nO3geVtjQCDwBV7bCXyYAxvQJ4Mv6E7zw@mail.gmail.com>
RECIPIENTS:
TO:
N
Neil Callahan
<ncallahan@rosemontseneca.com>
CC:
H
Hunter Biden
<hbiden@rosemontseneca.com>
J
John DeLoche
<john@rstp.com>
K
Katie Dodge
<kdodge@rosemontseneca.com>
W
William Lee
<will@rstp.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
I am going to be in arkansas with the family. On May 13, 2014 9:28 AM, "Neil Callahan (Rosemont Seneca)" < ncallahan@rosemontseneca.com> wrote: > Hi Katie, > > > > We have a very important 2nd meeting with Morgan Stanley in the Philly > suburbs. Friday May 23rd 1-3pm – can Rob and/or Hunter make it? Both > would be great as John cannot make it from the West Coast. I am sure they > can grab a 5pm Amtrak back to DC. > > > > Best, > > > > Neil > > > > > > Neil Callahan > > Rosemont Seneca Technology Partners > > Carnegie Hall Tower > > 152 West 57th, 47th Floor > > New York, NY 10019 > > 212-933-9965 (o) > > 917-945-9516 (m) > > 866-749-8879 (f) > > www.rstp.com > > > > Confidentiality Warning: This e-mail contains information intended only > for the use of the individual or entity named above. If the reader of this > e-mail is not the intended recipient or the employee or agent responsible > for delivering it to the intended recipient, any dissemination, publication > or copying of this e-mail is strictly prohibited. The sender does not > accept any responsibility for any loss, disruption or damage to your data > or computer system that may occur while using data contained in, or > transmitted with, this e-mail.If you have received this e-mail in error, > please immediately notify us by return e-mail. Thank you > > > > *From:* John DeLoche [mailto:jdeloche@rosemontseneca.com] > *Sent:* Tuesday, May 13, 2014 9:20 AM > *To:* Suzanne T. Cole > *Cc:* William Lee; John DeLoche; Neil Callahan > *Subject:* Re: Dates/Times Follow up Meeting Conshohocken- Please Respond > ASAP can we confirm May 19th? > > > > We are not moving Ascent because we can do MS on the 23rd. > > Sent from my iPhone > > > On May 13, 2014, at 6:17 AM, "Suzanne T. Cole" <suzanne@troyinv.com> > wrote: > > Since they are small and right in downtown SF, could you please move that > meeting date to accommodate MS? > > > > *From:* William Lee [mailto:will@rstp.com <will@rstp.com>] > *Sent:* Tuesday, May 13, 2014 9:14 AM > *To:* Suzanne T. Cole > *Cc:* John DeLoche; Neil Callahan > *Subject:* Re: Dates/Times Follow up Meeting Conshohocken- Please Respond > ASAP can we confirm May 19th? > > > > Ascent Private Capital. My preference is to tackle MS ASAP. > > William Lee > > Rosemont Seneca Technology Partners (RSTP) > > Sent from my iPhone > > > On May 13, 2014, at 6:05 AM, "Suzanne T. Cole" <suzanne@troyinv.com> > wrote: > > Who is the LP meeting with and can we move it? I’ve been emailing everyone > about that week and would like to get Morgan Stanley on track ASAP? Please > let me know & Thx STC > > > > *From:* William Lee [mailto:will@rstp.com <will@rstp.com>] > *Sent:* Tuesday, May 13, 2014 9:03 AM > *To:* Suzanne T. Cole > *Cc:* John DeLoche; Neil Callahan; Devon Archer; Sebastian Momtazi > *Subject:* Re: Dates/Times Follow up Meeting Conshohocken- Please Respond > ASAP can we confirm May 19th? > > > > 19th we have a LP meeting in the morning in SF. 23rd we are traveling > back from NY. Perhaps we have to do 28th, but I prefer not to wait so long > to meet with MS. > > > > John, what do you think? > > > > > William Lee > > Rosemont Seneca Technology Partners (RSTP) > > Sent from my iPhone > > > On May 13, 2014, at 5:34 AM, "Suzanne T. Cole" <suzanne@troyinv.com> > wrote: > > Can we confirm May 19th at 3:00pm? Thanks Suzanne > > *From:* Mueller, Katja [mailto:Katja.Mueller@morganstanley.com<Katja.Mueller@morganstanley.com>] > > *Sent:* Tuesday, May 13, 2014 8:32 AM > *To:* Suzanne T. Cole > *Subject:* RE: Follow up Meeting Conshohocken- Rosemont Seneca Technology > Partners II, L.P. > > > > Hi Suzanne, > > > > Looks like the following dates would work for a meeting in West > Conshohocken: > > > > May 19: after 3:00pm > > May 23: 1:00 – 3:00pm > > May 28: after 11:00am > > > > Please let me know what date/time is most convenient for the RSTP team. > > > > Thanks, > > Katja > > > > Katja Mueller > > *Morgan Stanley Alternative Investment Partners | AIP *100 Front > Street, 4th Floor | West Conshohocken, PA 19428 > Phone: +1 610 940-4623 > Katja.Mueller@morganstanley.com > www.morganstanleyaip.com > > Be carbon conscious. Please consider our environment before printing this > email. > > > > > *From:* Suzanne T. Cole [mailto:suzanne@troyinv.com <suzanne@troyinv.com>] > > *Sent:* Monday, May 12, 2014 5:41 PM > *To:* Markle, Neha Champaneria (IM); O'Brien, Kevin F (IM) > *Cc:* Sperans, James (IM); Espinal, Rose (IM); Mueller, Katja (IM) > *Subject:* Follow up Meeting Conshohocken- Rosemont Seneca Technology > Partners II, L.P. > *Importance:* High > > > > Hi Neha, Kevin and Jamey, > > Neha, as requested let’s look to schedule a follow up meeting the *week > of May 19 or May 26th *while the full *Rosemont Seneca Technology > Partners* team is on the East Coast. I will call to follow up to see what > day/time looks best for your team. > > > > Also, wanted to share the exciting news just published Thursday in > *Businesswire* regarding *Counsyl *, the third investment for *Rosemont > Seneca Technology Partners II, L.P*. You will be hearing much about this > company in the coming weeks. Counsyl has completely disrupted the lab > testing space, an industry that has been dominated by a few players and > seen no innovation in decades. Please take a moment to read about this > company and the launch of their next test for Cancer Screening. Will > follow up tomorrow on dates for Conshohocken. Best Regards, Suzanne > > > -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- > > *Counsyl Unveils First Highly Scalable, Automated Health Information > Platform and Gives People Low Cost Access to Vital Information about Their > Bodies* > > *Counsyl Launches Inherited Cancer Screen and Advances Family Prep Screen > Using Latest in Sequencing Technology To Deliver Results in Two Weeks or > Less; Raises $28M To Further Product Expansion, Bringing Total Financing to > $93M* > > *Counsyl Announces 250,000 Patients Screened and 14,000 Medical > Professionals Served -- Changing The Way People Make Choices About Their > Lives* > > May 08, 2014 09:00 AM Eastern Daylight Time > > SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE <http://www.businesswire.com/> > )--Counsyl<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=Counsyl&index=1&md5=616b98ea2f05b83fa61c75f46fe6518e>, > a technology company that gives people access to vital information about > their bodies, unveils the first scalable, comprehensive platform for people > to request and receive important health information in two weeks or less. > Counsyl launches the Inherited Cancer Screen starting with cancer > susceptibility genes *BRCA1* and *BRCA2* and advances its Family Prep > Screen using the latest in sequencing technology for couples planning to > start a family. > > “We’ve had to build our software systems from the ground up to offer a > simple and intuitive experience while managing complex order flows, > billing, fulfillment, and on-call counseling behind the scenes.” > > Counsyl also announces it has raised $28 million in Series D financing > co-led by Rosemont Seneca Technology Partners and Goldman Sachs Asset > Management bringing total financing to $93 million. The company will use > the funds to continue to invest in product development. By reducing the > cost of previously expensive laboratory procedures, Counsyl is giving > people and physicians access to medical data that is truly actionable. > Today this includes an Inherited Cancer Screen and Family Prep Screen, with > a future roadmap for delivering comprehensive screening for a wide range of > vital health information. > > “We want to make it easy and affordable for people to get screened for a > wide range of meaningful information that can have a real influence on > their health,” said Ramji Srinivasan, co-founder and Chief Executive > Officer of Counsyl. “We have made a conscious decision to screen for > diseases that give more people more choices in their lives.” > > *New Inherited Cancer Screen* > > Research shows that five to 10 percent of cancers are inherited. Counsyl’s > new *BRCA1 *and* BRCA2* screen informs men and women if they have > inherited a high risk for breast, ovarian, prostate, and pancreatic > cancers. Counsyl provides advanced knowledge that gives people options to > prepare, plan and do things to improve their health. For example, learning > this vital information can help doctors identify patients who are at high > risk for certain cancers. Doctors then can recommend more frequent, > advanced screening than the average guidelines suggest. Counsyl’s offerings > will soon include screens for other inherited cancers. > > Holly T., a hairstylist and mother from Camarillo, Calif., recently took > the Counsyl Inherited Cancer Screen as cancer runs in her family. Holly > said, “Knowing this information allows me to be proactive. I want to be > here for my kids, and I want to do everything I can to stay healthy.” > > *Advances to Family Prep Screen* > > Using sophisticated new sequencing technology, the Counsyl Family Prep > Screen gives couples who are planning to have a baby information about > hundreds of diseases they may unknowingly pass to future generations. A > positive result means that a prospective parent is a healthy “carrier” of a > genetic disease. When both parents are carriers of the same disease, they > have a one in four chance of giving birth to a child that is at risk for > that disease. These are health conditions where advanced knowledge can > change the way a couple approaches family planning. > > “You can take control of what you’ve been given and do something with it > for the positive,” notes Jennifer B., a nurse and mother who learned that > she and her husband were carriers of a severe disease, Smith-Lemli-Opitz > Syndrome, and chose specialized fertility treatments to have a healthy baby. > > *Launching Counsyl Complete Platform* > > In addition, the company is announcing Counsyl Complete, a platform for > online communication of results between physicians and patients. Physicians > who offer the Counsyl Complete service have access to a complete set of > online tools to allow them to easily track, monitor and follow up with > patients. > > Through a private online account, physicians can give results directly to > patients along with educational videos that explain the significance of the > findings. Patients who have additional questions can schedule complimentary > telephone counseling with an experienced medical professional from Counsyl > during daytime, evening and weekend hours. Compared to the standard wait > time of several weeks or months, physicians can now connect patients to a > genetic counselor online and expect to receive written documentation > following the call. > > “In my opinion, Counsyl Complete holds the promise to revolutionize the > way doctors and laboratories interact. This product is an innovation that > is overdue and a welcome partnership that we hope will prove to be an asset > to our practice and our patients," said Mitchell Nudelman MD, Bellegrove > Ob/Gyn. > > *Highly Automated Counsyl Lab* > > Counsyl integrates sophisticated technology with custom automation in its > CLIA-certified, CAP-accredited and NYS CLEP-permitted medical laboratory. > Designed from the ground up by a world-class team of scientists and > engineers, Counsyl’s lab has created unparalleled efficiencies in the > medical testing industry. > > “We are able to introduce new technology that allows us to process 10 > times more samples per person than traditional molecular labs,” said Dr. > Eric Evans, co-founder and Chief Science Officer at Counsyl. “Building an > efficient, scalable lab that uses sophisticated machinery and algorithms to > produce reliable data is a never-ending process. We’re constantly adding > new hardware and evaluating new technologies to ensure that millions of > people have access to critical information.” > > Counsyl uses custom-built robots to process blood and saliva samples > working alongside Counsyl’s team of scientists and engineers to > simultaneously analyze thousands of DNA samples with precision, accuracy > and unparalleled efficiency. > > When a sample reaches the laboratory, Counsyl’s robots use a unique > barcode to identify and track the sample from start to finish. Robotic > extraction and preparation of purified DNA ensures precision, which is a > vital aspect of Counsyl’s ability to analyze thousands of samples each day. > These robots are engineered from machines that are used for similarly > precise procedures, like laser eye surgery. > > “Our team of engineers can take raw medical data and turn it into a clear > online report,” said Rishi Kacker, Counsyl co-founder and VP of > engineering. “We’ve had to build our software systems from the ground up to > offer a simple and intuitive experience while managing complex order flows, > billing, fulfillment, and on-call counseling behind the scenes.” > > *Counsyl Medical Professionals* > > Members of the Counsyl clinical team are certified by the American Board > of Genetic Counseling and were recruited from top academic centers, > including Johns Hopkins Hospital, Weill Cornell Medical Center and UCSF > Medical Center. They are passionate about translating scientific data into > actionable information to help people make educated choices that are > consistent with their personal beliefs. > > *How To Get Counsyl* > > Step 1: Request > Request Counsyl online at www.counsyl.com<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=www.counsyl.com&index=2&md5=8c809446d814146cb5a69553d92a34c8>. > Counsyl will contact your physician to obtain medical approval. If you are > planning to use insurance, you can use the Counsyl price estimator<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=price+estimator&index=3&md5=4ff812d632e6c627b484fe2c46de8960> to > help calculate the cost. > > Step 2: Register > Receive a registered kit in the mail, along with instructions for sample > collection. > > Step 3: Submit > Submit a saliva specimen in the plastic tube provided within each kit and > send the sample back to Counsyl in a prepaid envelope. > > Step 4: Learn > Get your results within two weeks, with an option to review your findings > with a medical professional at Counsyl. > > *Pricing for Counsyl* > > Counsyl offers people an online price estimator<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=online+price+estimator&index=4&md5=306d058acdcff869f485945d9cf44b21> that > allows them to input their insurance information and receive a quote within > seconds. This upfront pricing transparency allows people to know what the > price will be before a test has been performed. Eligible patients typically > pay between $150-300 depending on the test and their insurance coverage. > > *About Counsyl* > > Counsyl is a technology company that strives to give millions of men and > women access to vital information about their bodies so they can > confidently make choices about their lives. Counsyl integrates > sophisticated technology with custom automation in its CLIA-certified, > CAP-accredited and NYS CLEP-permitted medical laboratory. The Counsyl > Family Prep Screen has already helped hundreds of thousands of people > discover critical information before having children, and the Counsyl > platform now includes inherited cancer screening. Counsyl has raised a > total of $93 million and is privately backed by Rosemont Seneca Technology > Partners, Goldman Sachs Asset Management, Founders Fund, Felicis Ventures, > David Drummond, and other high profile investors. > > > ------------------------------ > > NOTICE: If you have received this communication in error, please destroy > all electronic and paper copies and notify the sender immediately. > Mistransmission is not intended to waive confidentiality or privilege. > Morgan Stanley reserves the right, to the extent permitted under applicable > law, to monitor electronic communications. This message is subject to terms > available at the following link: http://www.morganstanley.com/disclaimers. > If you cannot access these links, please notify us by reply message and we > will send the contents to you. By messaging with Morgan Stanley you consent > to the foregoing. >
METADATA:
THREAD:
INDEX:
AdhhptkJxqJkR6hJT8uIAaQSzoN7HQ==
REFERENCES:
REPLY_TO:
<12ef01cf6eaf$3f48c6e0$bdda54a0$@rosemontseneca.com>
REFS:
<0CD60682-F35E-4B73-9133-A9E9D136FDCD@rstp.com>
<C90B1E38-2558-4CAC-AC47-DC4188F3B219@rstp.com>
<12ef01cf6eaf$3f48c6e0$bdda54a0$@rosemontseneca.com>
<EFEE123A-BE2A-4411-8DD8-E351509823A4@rosemontseneca.com>
<8E2B653F11CE174797540FC837F9045F7957CD@pit-exmbx-23.smarshexchange.com>
<8E2B653F11CE174797540FC837F9045F7957D3@pit-exmbx-23.smarshexchange.com>
<8E2B653F11CE174797540FC837F9045F7957D6@pit-exmbx-23.smarshexchange.com>